Literature DB >> 26335499

Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity.

Jin Feng1, Chao Huang2, Jonathan D Wren3, Dao-Wen Wang1, Jizhou Yan4, Jiexin Zhang5, Yujie Sun5, Xiao Han5, Xin A Zhang6.   

Abstract

Tetraspanin CD82 suppresses the progression and metastasis of a wide range of solid malignant tumors. However, its roles in tumorigenesis and hematopoietic malignancy remain unclear. Ubiquitously expressed CD82 restrains cell migration and cell invasion by modulating both cell-matrix and cell-cell adhesiveness and confining outside-in pro-motility signaling. This restraint at least contributes to, if not determines, the metastasis-suppressive activity and, also likely, the physiological functions of CD82. As a modulator of cell membrane heterogeneity, CD82 alters microdomains, trafficking, and topography of the membrane by changing the membrane molecular landscape. The functional activities of membrane molecules and the cytoskeletal interaction of the cell membrane are subsequently altered, followed by changes in cellular functions. Given its pathological and physiological importance, CD82 is a promising candidate for clinically predicting and blocking tumor progression and metastasis and also an emerging model protein for mechanistically understanding cell membrane organization and heterogeneity.

Entities:  

Keywords:  Cell movement; Lipid rafts; Tetraspanin; Tumor initiation; Tumor metastasis

Mesh:

Substances:

Year:  2015        PMID: 26335499     DOI: 10.1007/s10555-015-9585-x

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  17 in total

1.  Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro.

Authors:  Hui Yan; Xunda Ji; Jing Li; Lei Zhang; Peiquan Zhao
Journal:  Oncol Lett       Date:  2016-12-16       Impact factor: 2.967

2.  Identification of Key Genes as Early Warning Signals of Acute Myocardial Infarction Based on Weighted Gene Correlation Network Analysis and Dynamic Network Biomarker Algorithm.

Authors:  Chenxi Song; Zheng Qiao; Luonan Chen; Jing Ge; Rui Zhang; Sheng Yuan; Xiaohui Bian; Chunyue Wang; Qianqian Liu; Lei Jia; Rui Fu; Kefei Dou
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

3.  CD82-TRPM7-Numb signaling mediates age-related cognitive impairment.

Authors:  Yin Zhao; Tamas Kiss; Jordan DelFavero; Lu Li; Xing Li; Lu Zheng; Jie Wang; Chao Jiang; Jing Shi; Zoltan Ungvari; Anna Csiszar; Xin A Zhang
Journal:  Geroscience       Date:  2020-02-22       Impact factor: 7.713

Review 4.  Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring.

Authors:  Yangkun Zhou; Yang Yue; Siyu Fan; Qiaojun Jia; Xianfeng Ding
Journal:  Mol Biotechnol       Date:  2021-07-10       Impact factor: 2.695

5.  Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.

Authors:  Jundong Zhu; Chenkui Miao; Shouyong Liu; Ye Tian; Chao Zhang; Chao Liang; Aiming Xu; Qiang Cao; Zengjun Wang
Journal:  Onco Targets Ther       Date:  2017-12-06       Impact factor: 4.147

6.  Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer.

Authors:  Ronni Aram; Iris Dotan; Agnes Hotz-Wagenblatt; Dan Canaani
Journal:  Oncotarget       Date:  2017-06-28

7.  A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.

Authors:  W Li; M Hu; C Wang; H Lu; F Chen; J Xu; Y Shang; F Wang; J Qin; Q Yan; B J Krueger; R Renne; S-J Gao; C Lu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

8.  TIMP-1 and CD82, a promising combined evaluation marker for PDAC.

Authors:  Jiexin Zhang; Tijun Wu; Shanshan Zhan; Nan Qiao; Xu Zhang; Yunxia Zhu; Nan Yang; Yujie Sun; Xin A Zhang; David Bleich; Xiao Han
Journal:  Oncotarget       Date:  2017-01-24

Review 9.  Tspan2: a tetraspanin protein involved in oligodendrogenesis and cancer metastasis.

Authors:  Ibrahim H Yaseen; Peter N Monk; Lynda J Partridge
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

Review 10.  Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from Aloe species (Review).

Authors:  Hanna Svitina; Josias H Hamman; Chrisna Gouws
Journal:  Exp Ther Med       Date:  2021-06-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.